Unknown

Dataset Information

0

A High-Throughput Screening Identifies MICU1 Targeting Compounds.

ABSTRACT: Mitochondrial Ca2+ uptake depends on the mitochondrial calcium uniporter (MCU) complex, a highly selective channel of the inner mitochondrial membrane (IMM). Here, we screen a library of 44,000 non-proprietary compounds for their ability to modulate mitochondrial Ca2+ uptake. Two of them, named MCU-i4 and MCU-i11, are confirmed to reliably decrease mitochondrial Ca2+ influx. Docking simulations reveal that these molecules directly bind a specific cleft in MICU1, a key element of the MCU complex that controls channel gating. Accordingly, in MICU1-silenced or deleted cells, the inhibitory effect of the two compounds is lost. Moreover, MCU-i4 and MCU-i11 fail to inhibit mitochondrial Ca2+ uptake in cells expressing a MICU1 mutated in the critical amino acids that forge the predicted binding cleft. Finally, these compounds are tested ex vivo, revealing a primary role for mitochondrial Ca2+ uptake in muscle growth. Overall, MCU-i4 and MCU-i11 represent leading molecules for the development of MICU1-targeting drugs.

SUBMITTER: Di Marco G 

PROVIDER: S-EPMC7034061 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Mitochondrial Ca<sup>2+</sup> uptake depends on the mitochondrial calcium uniporter (MCU) complex, a highly selective channel of the inner mitochondrial membrane (IMM). Here, we screen a library of 44,000 non-proprietary compounds for their ability to modulate mitochondrial Ca<sup>2+</sup> uptake. Two of them, named MCU-i4 and MCU-i11, are confirmed to reliably decrease mitochondrial Ca<sup>2+</sup> influx. Docking simulations reveal that these molecules directly bind a specific cleft in MICU1,  ...[more]

Similar Datasets

Proteomics High-throughput screening and proteomic characterization of compounds targeting myeloid-derived suppressor cells
2023-08-15 | PXD043407 | Pride
Unknown High-Throughput Screening and Proteomic Characterization of Compounds Targeting Myeloid-Derived Suppressor Cells.
| S-EPMC10518717 | biostudies-literature
Unknown High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
| S-EPMC5127686 | biostudies-literature
Unknown Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.
| S-EPMC6946883 | biostudies-literature
Unknown High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin.
| S-EPMC3308743 | biostudies-literature
Unknown High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni.
| S-EPMC4851381 | biostudies-literature
Unknown Bayesian Multi-Plate High-Throughput Screening of Compounds.
| S-EPMC6015058 | biostudies-literature
Unknown High Throughput Screening for Colorectal Cancer Specific Compounds.
| S-EPMC6947929 | biostudies-literature
Unknown A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins.
| S-EPMC11342271 | biostudies-literature
Unknown A rapid and sensitive high-throughput screening method to identify compounds targeting protein-nucleic acids interactions.
| S-EPMC4417145 | biostudies-literature